Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2784883767;83768;83769 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
N2AB2620778844;78845;78846 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
N2A2528076063;76064;76065 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
N2B1878356572;56573;56574 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
Novex-11890856947;56948;56949 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
Novex-21897557148;57149;57150 chr2:178562590;178562589;178562588chr2:179427317;179427316;179427315
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Fn3-90
  • Domain position: 83
  • Structural Position: 117
  • Q(SASA): 0.6349
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/T rs397517723 -0.433 0.003 N 0.465 0.118 0.52170519339 gnomAD-2.1.1 1.22E-05 None None None None I None 0 0 None 0 0 None 0 None 0 2.68E-05 0
I/T rs397517723 -0.433 0.003 N 0.465 0.118 0.52170519339 gnomAD-4.0.0 4.11295E-06 None None None None I None 0 0 None 0 0 None 0 0 5.4013E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.1816 likely_benign 0.1998 benign -0.765 Destabilizing None N 0.317 neutral None None None None I
I/C 0.5778 likely_pathogenic 0.6162 pathogenic -0.869 Destabilizing 0.32 N 0.529 neutral None None None None I
I/D 0.7096 likely_pathogenic 0.7685 pathogenic 0.558 Stabilizing 0.32 N 0.55 neutral None None None None I
I/E 0.5891 likely_pathogenic 0.6478 pathogenic 0.513 Stabilizing 0.047 N 0.56 neutral None None None None I
I/F 0.1753 likely_benign 0.2069 benign -0.618 Destabilizing 0.02 N 0.475 neutral N 0.515921286 None None I
I/G 0.5779 likely_pathogenic 0.6236 pathogenic -0.962 Destabilizing 0.032 N 0.524 neutral None None None None I
I/H 0.5651 likely_pathogenic 0.6299 pathogenic -0.216 Destabilizing 0.692 D 0.553 neutral None None None None I
I/K 0.4662 ambiguous 0.5548 ambiguous -0.167 Destabilizing 0.002 N 0.529 neutral None None None None I
I/L 0.1171 likely_benign 0.1296 benign -0.352 Destabilizing None N 0.243 neutral N 0.476536179 None None I
I/M 0.1089 likely_benign 0.1136 benign -0.464 Destabilizing None N 0.251 neutral N 0.510958184 None None I
I/N 0.3158 likely_benign 0.3635 ambiguous -0.029 Destabilizing 0.262 N 0.559 neutral D 0.522961902 None None I
I/P 0.4284 ambiguous 0.4704 ambiguous -0.457 Destabilizing 0.32 N 0.549 neutral None None None None I
I/Q 0.4676 ambiguous 0.5166 ambiguous -0.167 Destabilizing 0.163 N 0.559 neutral None None None None I
I/R 0.3476 ambiguous 0.4298 ambiguous 0.228 Stabilizing 0.158 N 0.549 neutral None None None None I
I/S 0.2408 likely_benign 0.2713 benign -0.693 Destabilizing 0.024 N 0.519 neutral N 0.510822111 None None I
I/T 0.0951 likely_benign 0.1092 benign -0.615 Destabilizing 0.003 N 0.465 neutral N 0.494929939 None None I
I/V 0.0553 likely_benign 0.061 benign -0.457 Destabilizing None N 0.193 neutral N 0.420856254 None None I
I/W 0.7852 likely_pathogenic 0.8065 pathogenic -0.582 Destabilizing 0.89 D 0.559 neutral None None None None I
I/Y 0.538 ambiguous 0.5966 pathogenic -0.326 Destabilizing 0.021 N 0.529 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.